A collaborative research team from ORNL and other national laboratories is using artificial intelligence and computational screening techniques — in combination with experimental validation — to identify and design drug therapies to target the SARS-CoV-2 virus. Here are five promising approaches.
![Sara Shoemaker](/sites/default/files/styles/staff_profile_image_style/public/2021-04/2021-P02584.jpg?h=5a83e0d3&itok=GW8Lvf44)